FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1527461000168108: bupivacaine hydrochloride monohydrate 20 mg / 4 mL + glucose monohydrate 320 mg / 4 mL intrathecal injection, 4 mL ampoule (medicinal product unit of use)

Status: current, Defined. Date: 31-Mar 2021. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4528741000168111 bupivacaine hydrochloride monohydrate 20 mg / 4 mL + glucose monohydrate 320 mg / 4 mL intrathecal injection, 4 mL ampoule (medicinal product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4528751000168113 bupivacaine hydrochloride monohydrate 0.5% (20 mg/4 mL) + glucose monohydrate 320 mg/4 mL intrathecal injection, ampoule en Synonym Active Case sensitive Australian Medicines Terminology module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
bupivacaine hydrochloride monohydrate 0.5% (20 mg/4 mL) + glucose monohydrate 320 mg/4 mL intrathecal injection, ampoule Is a medicinal product unit of use true Inferred relationship Some
bupivacaine hydrochloride monohydrate 0.5% (20 mg/4 mL) + glucose monohydrate 320 mg/4 mL intrathecal injection, ampoule Is a bupivacaine + glucose true Inferred relationship Some
bupivacaine hydrochloride monohydrate 0.5% (20 mg/4 mL) + glucose monohydrate 320 mg/4 mL intrathecal injection, ampoule has manufactured dose form intrathecal injection true Inferred relationship Some
bupivacaine hydrochloride monohydrate 0.5% (20 mg/4 mL) + glucose monohydrate 320 mg/4 mL intrathecal injection, ampoule has Australian BoSS bupivacaine hydrochloride monohydrate true Inferred relationship Some 1737230097
bupivacaine hydrochloride monohydrate 0.5% (20 mg/4 mL) + glucose monohydrate 320 mg/4 mL intrathecal injection, ampoule has intended active ingredient bupivacaine true Inferred relationship Some 1737230097
bupivacaine hydrochloride monohydrate 0.5% (20 mg/4 mL) + glucose monohydrate 320 mg/4 mL intrathecal injection, ampoule has Australian BoSS glucose monohydrate true Inferred relationship Some 1736425340
bupivacaine hydrochloride monohydrate 0.5% (20 mg/4 mL) + glucose monohydrate 320 mg/4 mL intrathecal injection, ampoule has intended active ingredient glucose true Inferred relationship Some 1736425340
bupivacaine hydrochloride monohydrate 0.5% (20 mg/4 mL) + glucose monohydrate 320 mg/4 mL intrathecal injection, ampoule has unit of use ampoule true Inferred relationship Some 1614484699
Inbound Relationships Type Active Source Characteristic Refinability Group
Marcain Spinal Heavy intrathecal injection, 4 mL ampoule Is a True bupivacaine hydrochloride monohydrate 0.5% (20 mg/4 mL) + glucose monohydrate 320 mg/4 mL intrathecal injection, ampoule Inferred relationship Some
bupivacaine hydrochloride monohydrate 0.5% (20 mg/4 mL) + glucose monohydrate 320 mg/4 mL intrathecal injection, 5 x 4 mL ampoules has MPUU True bupivacaine hydrochloride monohydrate 0.5% (20 mg/4 mL) + glucose monohydrate 320 mg/4 mL intrathecal injection, ampoule Inferred relationship Some 619168280

Reference Sets

Medicinal product unit of use reference set

Back to Start